Furthermore, ARX788 showed notable anti-tumor effect against HER2-positive and HER2 low-overexpressing tumors, as well as efficacy in T-DM1-resistant models, in xenograft experiments conducted on patients with breast and gastric malignancies [100]. The gene discussed is ERBB2; the disease is neoplasm.